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The Patient Health Engagement Scale (PHE-s) was designed to assess the emotional
and psychological attitudes of patients’ engagement along their healthcare management
journey. The aim of this study was to validate a culturally adapted Chinese version
of the PHE-s (CPHE-s). Three hundred and seventy-seven participants were recruited
from eight community health centers in a sample of patients with chronic disease in
Hunan Province, China. The original Italian PHE-s was translated into Mandarin Chinese
using a standardized forward–backward translation. The Rasch model was utilized
and presented uni-dimensionality and good items fitness of the PHE-s. The internal
consistency was 0.89 and the weighted Kappa coefficients of the items (test–retest
reliability) ranged from 0.52 to 0.79. Both principal component analysis and confirmatory
factor analysis supported a single-factor structure of the PHE-s. In testing the external
validity, the PHE-s showed a significant moderate correlation with patient activation but
not with medicine adherence behavior, which requires further exploration. The result
suggested that the PHE-s is a reliable and valid instrument to assess the level of patient
engagement in his or her own health management among chronic patients in China.
Further analysis of reliability and validity should be assessed among other patient cohorts
in China, and future directions for testing changes after patient engagement interventions
should be developed by exploring some clinical relevance.
Keywords: patient engagement, patient engagement measure, patient health engagement scale, patient
activation, psychometric properties
INTRODUCTION
Chronic diseases are the leading health concerns of the twenty-first century. Due to longer
life expectancy and an aging population, control and prevention measures are urgently needed
in the healthcare system (Ali et al., 2015). Deaths from chronic diseases rose by just under 8
million between 1990 and 2010, accounting for two-thirds of global deaths, half of all disabilities,
and rapidly growing costs (Lozano et al., 2012). The low- and middle-income countries are
projected to experience the greatest challenge resulting from chronic disease, which makes
up 80% of the causes of death among the world’s population (Bloom et al., 2011) and bears
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more serious burden (Boutayeb, 2006). In China, rapid
transitions are also occurring on account of demography
and epidemiology (Zhou et al., 2016). According to the
latest data from the “2015 Report on Chinese Nutrition
and Chronic Disease” released by the National and Family
Planning Commission (NHFPC) (http://www.chinadaily.com.
cn/m/chinahealth/2015-07/08/content_21224293.htm), the
prevalences of hypertension and diabetes among Chinese adults
in 2012 were 25.2 and 9.7%, respectively. The incidence rate of
cancer was also on the rise, reaching 235 per 100,000 people in
2013. Moreover, 533 out of every 100,000 Chinese residents died
from chronic disease in 2012, resulting in 86.6% of all deaths with
cardio-cerebrovascular disease, cancer, and chronic respiratory
disease as the top causes (Yang et al., 2013).
As a way of combating this growing health crisis, health
systems are under a paradigm shift in the planning and delivery
of healthcare from patients being viewed as passive recipients
of care to being more active and accountable for their own
health (Osborn and Squires, 2012). More and more theories
and practices have advocated considering patients to be key
resources in self-management of chronic diseases. The evidence-
based Chronic Care Model illustrated the importance of
productive interactions between patients and health practitioners
and also highlighted the crucial connection between patient
engagement and desirable health outcome (Wagner et al.,
2001; Bodenheimer et al., 2002; Wasson and Coleman, 2014).
The increasing evidence has also demonstrated that patients’
engagement in their own health care process is a core generic
components to achieving patient-centered care and successful
health management (Ishikawa and Yano, 2011; Miles and
Mezzich, 2011). This is particularly true in the case of chronic
disease (Simmons et al., 2014). These growing findings in
previous serial studies have shown that patients who are more
active and engaged in healthcare frequently report improved
patient satisfaction and better care experiences, more effective
medicationmanagement and improvedmedication safety, higher
quality of life, access to health behaviors, and better clinic
outcomes, even likely using fewer health care services and
contributing to a reduction of healthcare costs (Coulter, 2012;
Osborn and Squires, 2012; Hibbard and Greene, 2013; Barello
and Graffigna, 2014; Cunningham, 2014; Laurance et al., 2014).
Clearly, patient engagement is perceived to be of importance
in the health care system. It is essential to have a good
understanding of the level of patient engagement by assessing
what works, how it works, and whether engagement efforts are
improving outcomes over time (Carman et al., 2013; Wasson
and Coleman, 2014). However, to the best of our knowledge,
the measurement of patient engagement remains a substantial
issue for policy makers and healthcare practitioners at present;
few scientifically validated assessment tools exist to help identify
patients’ level of engaging in their care. Most generic instruments
developed in the field of chronic disease—such as the Patient
Enablement Instrument designed to capture patients’ ability to
Abbreviations: PHE, patient health engagement; PHE-s, patient health
engagement scale; CPHE-s, The Chinese version of patient health engagement
scale.
understand the nature of diseases and copy with their health
problems (Howie et al., 1998); the Partners in Health scale,
which is a generic assessment scale for patients managing their
chronic medical conditions (Battersby et al., 2003); the Patient
ActivationMeasure, which provided an evaluation of individuals’
knowledge, skill, and confidence for managing their own health
or healthcare (Hibbard et al., 2005); and the Self-Management
Ability Scale focused on self-management abilities in relation
to well-being (Cramm et al., 2012) can be grouped into one
category aimed at assessing the patients’ ability to self-manage
disease conditions (Eikelenboom et al., 2015). In fact, apart from
oriented measurements toward health literacy and behavioral
components of patients’ self-management, increasing evidence
was also accumulating to learn from patients’ life stories and
call on giving birth to patients’ chronic illness trajectory across
time (Morales-Asencio et al., 2014), particularly on the emotive
component of patient engagement. Those were conceived of as
the patients’ process elaborating and adjusting to the disease and
often appeared to be the first movers of patients’ confidence and
ability to increase health literacy and reinforce self-management
behaviors (Hudson et al., 2014; Graffigna and Barello, 2016).
Several existing studies have demonstrated that patients with
increased and positive emotion and psychology to attend their
own health care are more likely to perform improved patient
activation (Hibbard and Mahoney, 2010), enact specific health
behavior (Graffigna et al., 2015a), and even have ameliorative
health-related biological markers (Ismail et al., 2004). On the
contrary, patients are often being debilitated because of emotive
disorders, and which may further affect their behavioral choices
(Shubin et al., 2015) and may even develop into a vicious cycle
(Hibbard and Mahoney, 2010).
However, minimal attention has been given in this aspect to
evaluate the emotional and psychological dynamic of patients’
engagement experiences along their care management journeys
using measures like the Patient Health Engagement Scale (PHE-
s), which was recently developed by Graffigna et al. (2015a). Even
though the psychometric properties of the PHE-s may not yet
be well established, it was still able to be generalized in other
countries, because it offered a measure of patient engagement for
the first time that more holistically considers the psychological
elaboration of the patient based on a rigorous conceptualization
model—namely, PHE model. In this model, patient engagement
was deemed to be a dynamic and evolutionary process that
features four stages: blackout, arousal, adhesion, and eudaimonic
project (Graffigna and Barello, 2014; Graffigna et al., 2014).
The original Italian version of the PHE-s has only five items
and is easy to answer due to its shortness. Each item has
seven response options that allow patients to position themselves
along a continuum of patient engagement experiences (according
to the phases featured by the PHE model). The scale has
an ordinal nature and is easy to apply. The instrument can
be self-administered by the patient and gives interesting and
pragmatic cues to the clinicians in order to best customize their
communicational and relational strategies aimed at sustaining
patient engagement.
At present, a Chinese version of the PHE-s remains
unavailable. Therefore, in the current study, we aimed to translate
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the original Italian PHE-s into Chinese Mandarin and to evaluate
its psychometric properties in a group of patients with chronic
disease in China.
MATERIALS AND METHODS
Translation and Culture Adaptation of the
PHE-s
In this study, the original version of the PHE-s was translated
as recommended by the WHO (World Health Organization)
procedures for cross-cultural validation and adaptation of a self-
report instrument. The method involved the following steps:
(1) forward translation by two bilingual language experts who
translated the PHE-s from Italian into English; (2) forward
translation by two bilingual language experts who translated
the PHE-s from English to Mandarin Chinese; (3) experts’
qualitative interviews in order to evaluate semantic and content
equivalence, which included eight professionals with broad work
experience in chronic care, health research, clinical psychology,
and translating; (4) back translation by two additional bilingual
experts who translated the Chinese version scale back into
English; (5) back translation by two additional bilingual experts
who translated the scale from English into Italian while the
original author was invited to distinguish the back translation
from the English and original versions; and (6) a pilot test
among 27 patients with chronic diseases to check the readability
and understandability of items and cognitive equivalence of
the translation. The final version of the Chinese PHE-s
(CPHE-s) was established by consensus and attached online as
Appendix I.
Other Instruments
Patient Activation Measure—Short Form
The American short form of the Patient Activation Measure
(PAM13) developed by Hibbard et al. (2005) is an interval-level,
unidimensional, Guttman-like scale to provide an assessment
of the potential or capacity for patients to be engaged in
their health care from three aspects of disease self-management
including patient knowledge, skills, and confidence. The response
categories of the 13-item scale ranged from strongly disagree
to strongly agree and “not applicable.” The raw scores were
converted from the continuous Rasch item response theory logit
scale to activation scores between 0 and 100 with higher scores
indicating greater patient activation. The scale has been widely
used and has been shown to be reliable and validated in many
different contexts (Maindal et al., 2009; Brenk-Franz et al., 2013;
Brucki et al., 2014; Graffigna et al., 2015c; Moljord et al., 2015). In
this study, we used the Mainland Chinese version of the PAM13
(PAM13-C) obtained by following theWHO guidelines for cross-
cultural adaptation of instruments, and permission for use was
obtained from Insignia Health, Inc. The Cronbach’s alpha of the
PAM13-C was 0.84, indicating good internal consistency among
the items. A partial credit Rasch model was used to assess the
item fit of the PAM13-C. The item statistics ranged from 0.81
to 1.25 for the infit mean square (MNSQ) and from 0.82 to 1.12
for the outfit MNSQ, suggesting that all the items are productive
measurements (Linacre, 2011).
Morisky Medication Adherence Scale
The Morisky Medication Adherence Scale (MMAS-4) (Morisky
et al., 1986) is a 4-item self-reported scale used to assess
patients’ medication-taking behavior. The MMAS-4 addressed
the essential reasons for non-adherence including forgetting,
carelessness, and stopping the drug when feeling better or
worse. Response categories were yes and no for each item with
a dichotomous response. Scores obtained from the MMAS-4
ranged from 0 to 4. Scores of 0, 1 to 2, and 3 to 4 were classified
as high, medium, and low adherence, respectively. The Chinese
version of the MMAS-4 was available, and the psychometric
properties have been established, showing adequate internal
consistency with a Cronbach’s alpha coefficient of 0.76 for the
total scale (Xu et al., 2007; Li et al., 2010).
Demographic and Clinical Variables
Participants were asked for information regarding age
(continuous), gender, marital status, educational attainment,
occupational status, type of diagnosis, and insurance type.
Education attainment level was categorized as “primary school
and below,” “junior secondary school,” “senior and specialized
secondary school,” and “college or higher.”
Procedure
To enhance representativeness, a hierarchical sampling process
was employed to recruit participants with chronic illnesses from
community health centers in Hunan Province of China. Hunan
Province was stratified to four geographic areas, and one city was
randomly selected from each area. Data from the Hunan Health
Ministry was used to compile a sampling frame of all community
health centers in each of the four selected cities. All community
health centers that agreed to participate in the study were
provided with unique code numbers using SPSS 23.0, and then
two community health centers were randomly selected as settings
for recruiting participants. One hundred and ten participants
were targeted in the two selected community centers in each
of the four cities and recruited using a consecutive sampling
method if they met the following selection criteria: (1) age >
18 years, (2) diagnosed with one or more chronic disease, and
(3) following a chronic treatment for their diseases. Participants
with cognitive impairment, uncontrolled psychiatric illness, or
serious hearing impairment were excluded from the study. A
total of 377 participants were recruited between November,
2015, and February, 2016, and completed the questionnaire; the
sample frame and the detailed numbers of participants from
each city are presented in Figure 1. Moreover, a sub-sample of
27 participants from one community health center in Changsha
completed a test–retest evaluation of the CPHE-s through a
telephone investigation after a 2-week interval.
ETHICS STATEMENT
Permissions were obtained from the authors and copyright
owners of the original scale development research. The study was
approved by the Ethical Committee of Xiang Ya Nursing School,
Central South University in China. All participants received a
short study description and were asked to give oral permission
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FIGURE 1 | Flow chart of sample frame and numbers of participants from each city.
to take part. Patients were also informed about anonymity and
their right to withdraw from the study at any time without
consequences. The results were analyzed at the group level
and for scientific purposes exclusively. There are no vulnerable
populations in this study.
DATA ANALYSIS
The data were entered by EpiData 3.02 and analyzed using
IBM SPSS 23.0, Amos 23.0, and R 3.2.4. Appropriate descriptive
statistics for ordinal data were used to summarize and present the
data. The content validity was assessed through the application of
the content validity index (CVI), and the item-level CVI (I-CVI)
and Scale-level Index Average (S-CVI/Ave) were reported to
compare the relevance of the translated Chinese version with the
English version in this study (Polit and Beck, 2012). The partial
credit Rasch model specifying additivity and uni-dimensionality
was employed to assess the item fit of the CPHE-s. The infit
MNSQ statistic was used to assess the item fit. An infit value
of an item falling between 0.5 and 1.5 indicates that the item
is productive for the underlying measurement (Linacre, 2011).
The internal consistency of the items of the CPHE-s was assessed
using Ordinal Alpha via Empirical Copula Index (Bonanomi
et al., 2012, 2015) and inter-item polychoric correlation given the
ordinal nature of the items. A reliability index ≥ 0.7, 0.8, or 0.9
can be interpreted as acceptable, good, or excellent, respectively
(Gliem and Gliem, 2003). Test–retest reliability of the instrument
was assessed using weighted kappa. Weighted kappa values
can be interpreted as follows: ≤0.20 as poor, 0.21–0.40 as fair,
0.41–0.60 as moderate, 0.61–0.80 as substantial, and >0.8 as
almost perfect (Altman, 1991). Principal component analysis
(CATPCA) was performed to identify the factor structure of the
polytomous items of the CPHE-s. Confirmatory factor analysis
(CFA) was performed to study the replicability of the factor
structure obtained by CATPCA. The estimation method was
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asymptotically distribution free, particularly suitable for ordinal
data and not-Gaussian distributions. Measurement invariance
by gender was also investigated. Finally, to assess the external
validity of the CPHE-s, we evaluated the correlations between
patient engagement (CPHE-s) and the PAM13 as well as
medication adherence (MMAS-4) using SPSS 23.0 with Pearson’s
correlation coefficient. We expected high positive correlations
between the CPHE-s and PAM13 as well as the MMAS-4.
Significance level was set to α= 0.05.
RESULTS
Translation and Adaptation
During the translation process, some modifications were
necessary to address cultural differences between Western and
Eastern countries. For example, the word “blackout” refers
to a sudden status of power outages or flameout that is too
abstract to understand for Chinese, especially elders with chronic
disease. Therefore, we translated “I feel like I have blacked out”
into “I feel my mind/brain goes blank.” Further, there is no
obvious difference between “aware” and “conscious,” which both
illustrate a status of attitude or cognition. “I have gained some
understanding gradually” and “I know my disease/status” were
used to distinguish two different intensities. In the current study,
an expert panel including three clinicians experienced in chronic
care or psychology from university teaching hospitals and two
faculty members from university was asked to rate each item
of the CPHE-s. The I-CVI was between 0.80 and 1.00, and the
S-CVI/Ave was 0.92 in the final version of the CPHE-s. These
results indicate acceptable content validity for the CPHE-s. More
detailed information of the forward and back translations is
presented in Appendix II.
Sample
Among 440 chronic patients who participated in the current
study, 377 completed the survey for the psychometric analysis
for an overall response rate of 85.7%. The most common reasons
for refusal were lack of time and poor physical condition on the
day of the survey. Demographic and clinic characteristics of the
participants are summarized in Table 1. It was noted that, for
these clinic diagnoses, the groups were not independent since
most of the participants had more than one chronic disease.
Additionally, 27 out of 30 participants from a randomly selected
sub-sample completed the test–retest evaluation of the CPHE-s
after a 2-week interval. Of those, 59.3% were women, and 40.7%
were men with a mean age of 53.8 years (SD = 11.0) and a range
of 34–78 years.
Responses to the Chinese Patient Health
Engagement Scale (CPHE-s)
Since the Pearson correlation between the ordinal factorial score
andmedian is very high (equal to 0.86), the median of the CPHE-
s is considered to be a robust and efficient estimator of the
real latent score of the construct—namely, the level of patient
engagement. Table 2 provides the item-level descriptive statistics
for all items. Given the ordinal nature of the items, the median
and the Shannon Entropy Index were calculated as tendency
TABLE 1 | Demographic and clinical characteristics of the sample (n =
377).
Characteristics n (%)
AGE (YEARS)
< 60 107 (28.4)
60–74 182 (48.3)
≥ 75 88 (23.3)
GENDER
Male 172 (45.6)
Female 205 (54.4)
MARITAL STATUS
Never married 1 (0.3)
Married 316 (83.8)
Divorced 6 (1.6)
Windowed 54 (14.3)
EDUCATION
Primary school and below 122 (32.4)
Junior secondary school 124 (32.9)
Senior and specialized secondary school 80 (21.2)
College or higher 51 (10.75)
EMPLOYMENT
Student 1 (0.3)
Unemployed 131 (34.7)
Retired 209 (55.4)
Employed 36 (9.5)
INSURANCE TYPE
UEBMI 208 (55.2)
URBMI 122 (32.4)
NRCMS 45 (11.9)
Uninsured 2 (0.5)
CHRONIC DISEASES(%)
Hypertension 271 (71.9)
Diabetes 110 (29.2)
Cerebrovascular disease 50 (13.3)
Cardiovascular disease 102 (27.1)
COPD 41 (10.9)
Cancer 15 (4.0)
Rheumatoid arthritis 9 (2.4)
Osteoarthritis 21 (5.6)
Osteoporosis 1 0.3)
Thyroxine disorder 5 (1.3)
Uremia 4 (1.1)
Asthma 1 (0.3)
Hepatitis 6 (1.6)
Hypercholesterolemia 9 (2.4)
Depression 1 (0.3)
UEBMI, Urban employee basicmedical insurance; URBMI, Urban residents’ basicmedical
insurance; NRCMS, New rural cooperative medical system.
central and dispersion indices, respectively. Furthermore, there
was no severe floor or ceiling effect for the summary score
of the CPHE-s since only 17 (4.5) and 44 (11.7%) of the
participants achieved the lowest and highest possible scores,
respectively.
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TABLE 2 | Item-level descriptive statistics for ranks on the CPHE-s.
CPHE-s Rank Minimum Maximum Median Shannon
item range entropy
Item 1 1–4 1 4 3 0.77
Item 2 1–4 1 4 3 0.77
Item 3 1–4 1 4 3 0.81
Item 4 1–4 1 4 3 0.84
Item 5 1–4 1 4 3 0.83
Item Analysis
A Partial Credit Rasch Model was implemented to further
investigate whether the CPHE-s was uni-dimensional and
whether all items fit the model well. Infit MNSQ statistic was
computed to check whether the items fit the expected model.
MNSQ determines how well each item contributes to defining
a single underlying construct (uni-dimensionality). Infit is more
sensitive to misfit responses to items closest to the person’s ability
level.
The logit measures and infit MNSQ statistics of the CPHE-
s items are given in Table 3. The logit measures of the items
ranged from 0.47 to 0.50, indicating that the item difficulties are
not greatly varied. None of the items had infit MNSQ statistics<
0.5 or > 1.5, suggesting that all the items are productive for the
underlying measurement (Linacre, 2011). The person separation
index (PSI) was calculated to evaluate the reliability in the Rasch
Model (PSI= 0.884).
RELIABILITY
Internal Consistency and Test–Retest
Reliability
The CPHE-s had very good internal consistency since the value
of the Ordinal Alpha via Empirical Copula was equal to 0.89. In
Table 4, the Ordinal Alpha was evaluated after deleting individual
items. Each item contributed significantly to the PHE-s score.
The internal consistency of the CPHE-s was satisfactory. The
Ordinal Alpha if item is deleted and weighted kappa coefficients
(test–retest reliability) are shown in Table 4. The weighted Kappa
coefficients of the items ranged from 0.52 to 0.79, suggesting that
the strength of agreement of the test–retest values of the CPHE-s
items could be interpreted as moderate to good (Altman, 1991).
Internal Structure
Exploratory Analysis
The sample has been divided randomly into two sub-groups with
an exclusive and exhaustive procedure: Group 1 (n = 227, 55.9%
women, aged 36–90 years old; M = 66.1 years, SD = 9.8) for
exploratory analysis and Group 2 (n = 150, 52% women, aged
26–87 years old; M = 65.4 years, SD = 10.6) for confirmatory
analysis.
An exploratory categorical CATPCA was conducted on the
final CPHE-s in Group 1 because of the ordinal nature of the
items. An initial analysis was performed without any restriction
on the number of metric factors to be estimated. The initial
TABLE 3 | Logit measures and mean square Infit statistics for the partial
credit Rasch model of the CPHE-s.
CPHE-s Logit measure (error) Infit MNSQ
Item 1 0.11 (0.16) 1.43
Item 2 −0.47 (0.16) 1.22
Item 3 0.50 (0.16) 0.79
Item 4 −0.13 (0.16) 0.74
Item 5 0.00 (0.16) 0.77
TABLE 4 | Reliability indices for the CPHE-s.
CPHE-s item Ordinal alpha if item deleted Test–retest reliability
weighted kappa
Item 1 0.88 0.74
Item 2 0.87 0.65
Item 3 0.86 0.52
Item 4 0.85 0.53
Item 5 0.85 0.79
analysis yielded one factor with eigenvalue 4.1, explaining 87.1%
of the total variability. Table 5 shows the factor loadings for the
one solution of the CATPCA. All factor loadings had a very high
value (>0.8).
All the conducted analyses (Rasch Model, Item fit analysis,
PSI, Ordinal Alpha, eigenvalue, and explained variability of the
first component of CATPCA) confirmed the uni-dimensionality
of the scale. Table 6 gives the inter-item polychoric correlation
matrix of the CPHE-s. The average inter-item polychoric
correlation is a subtype of internal consistency reliability. It
is obtained by taking all the items on a test that probes
the same construct, determining the polychoric correlation
coefficient for each pair of items, and finally taking the average
of all of these polychoric correlation coefficients. All inter-
item polychoric correlations were higher than 0.7, indicating
good inter-correlation between the items. The average inter-
item polychoric correlation is equal to 0.84, indicating a high
correlation between items.
Confirmatory Analysis
CFA (Figure 2) was performed on Group 2 to study the
replicability of the factor structure obtained by CATPCA.
The estimation method was asymptotically distribution
free, particularly suitable for ordinal data and not-Gaussian
distributions. To evaluate the closeness of the hypothetical model
to the empirical data, multiple goodness-of-fit indexes were used,
including the ratio of the chi-square to degrees of freedom
(χ2/df ), the Comparative Fit Index (CFI), the Standardized Root
Mean Square Residual (SRMR), the Goodness of Fit Index (GFI),
and the Root Mean Square Error of Approximation (RMSEA).
To test the model, each variable was allowed to load on only one
factor, and one variable loading in the latent factor was fixed at
1.0. For the remaining factor loadings, residual variances were
freely estimated.
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TABLE 5 | Factor loadings from CATPA – One factor solution.
CPHE-s item One factor solution
Item 1 0.74
Item 2 0.71
Item 3 0.84
Item 4 0.89
Item 5 0.88
TABLE 6 | Polychoric correlation matrix for the items of CPHE-s.
CPHE-s Item 1 Item 2 Item 3 Item 4 Item 5
Item 1 – 0.94 0.79 0.75 0.72
Item 2 – 0.80 0.81 0.79
Item 3 – 0.93 0.90
Item 4 – 0.98
Item 5 –
FIGURE 2 | CFA on CPHE-s: Standardized estimates.
CFA showed reasonable goodness of fit indices. The fit indices
met the criteria of fit for the hypothesized one-factor structure.
Chi square (c2 = 6.65, df = 4, p = 0.156) value and goodness of
fit indices (CFI = 0.983, SRMR= 0.014, GFI = 0.979, RMSEA
= 0.067) suggested that the model is coherent with the data.
The analysis of modification indices did not suggest any relation
between the error covariance of the items, avoiding overlapping
problems.
To verify the validity and generalizability of the factor
structure, a multi-group confirmatory analysis tested
measurement invariance in the two subsamples divided by
gender. Table 7 shows the verified invariance hypothesis. The
1χ2 between the unconstrained and constrained models did not
yield significant results. The factor structure was invariant by
gender.
External Validity
The external validity of the CPHE-s was assessed by correlating
the median score of the scale with the PAM-13 and MMAS-
4 scores using Pearson’s correlation coefficient. A moderate
correlation was found between the CPHE-s and PAM-13 (r =
TABLE 7 | Multigroup CFA by gender.
Model χ2 Df RMSEA CFI ∆χ2 (df) P
Unconstrained 6.6 4 0.059 0.971 – –
Invariant factor loading 21.6 16 0.048 0.994 14.9 (12) 0.25
0.43, p < 0.001). However, there was no significant correlation
between the CHPE-s and MMAS-4 (r =−0.04, p= 0.464).
DISCUSSION
This cross-sectional study provided the first report on the
translation and validation of the PHE-s into the Chinese
Mandarin language. The Rasch analysis presented a series of
good infit values (ranging from 0.74 to 1.43) for each item of
the CPHE-s. The data demonstrated good internal consistency of
the PHE-s for patients with chronic disease through satisfactory
Ordinal Alpha (α = 0.89), which is higher than the original
Italian Cronbach coefficient (α = 0.85) (Graffigna et al., 2015a),
and good test—retest analysis (the weighted Kappa coefficients
of the items ranging from 0.52 to 0.79) (intra-class correlation
coefficient = 0.68), which is lower than the value of the Italian
measure (Graffigna et al., 2015a) but is still accepted. The
exploratory categorical CATPCA andCFA suggest that the PHE-s
belongs to a single-factor and uni-dimensionality scale.
To assess the external validity of the CPHE-s, the CPHE-
s factor scores were first evaluated in relation to the PAM13
with strong psychometric properties as a golden standard,
and the Pearson’s correlation coefficient was 0.43, which is
consistent with the Italian finding (Graffigna et al., 2015a).
With some degree of conceptual overlapping, the terms
“patient engagement” and “patient activation” are often used
interchangeably. Patient activation contributed to describe the
degree of patient engagement as an active agent inmanaging their
own health, and higher levels of activation have been associated
with greater patient engagement in health care (Carman et al.,
2013; Hibbard and Greene, 2013; Graffigna et al., 2015a,b;
Menichetti et al., 2016).
In contrast to the Italian data (Graffigna et al., 2015a),
the Chinese results failed to support significant and negative
associations between PHE and MMAS-4 scores. One plausible
explanation for this finding stems from previous studies (Young
et al., 2014; Awwad et al., 2015) that suggest that medicine
adherence reports may tend to be skewed in favor of reporting
higher adherence. Some responders might not disclose non-
adherence as it might be deemed undesirable behavior, especially
in the face-to-face investigation. Another explanation for this
finding is that a four-item scale is not sufficient to represent
the entire domain of the medication adherence construct
(Morisky and DiMatteo, 2011). The eight items of the MMAS,
which were shown to have higher reliability than the original
four-item scale (Morisky et al., 2008), should be taken into
consideration to further explore the correlation between patient
health engagement level and medication adherence in future
research.
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Concerning potential shortcoming and limitations, first,
this study is liable to recall bias like other studies based
on self-reported measures, because it is hard to differentiate
between patients who have actually addressed a high level
of patient engagement and those reporting a high level
of patient engagement for social desirability. Second, the
relative heterogeneity of samples may be regarded as a
weakness. Participants enrolled in community health centers
represent a wide range of patients with chronic diseases,
including patients with acute care, patients undergoing routine
examinations, and patients with multi-morbidity. This might
be negatively affected and lead to some errors in concurrent
analysis like the relationship between patient health engagement
and medicine-taking behaviors. Hence, further research is
warranted to confirm the validation of the CPHE-s in
a stratified manner representative of the Chinese chronic
population.
In conclusion, our research adds to the accumulating
evidence that the PHE-s has good validity and reliability
in the context of Eastern culture. Healthcare practitioners
can use it in primary care settings to better understand
the patient engagement levels among patients taking part
in their own health management. Differences in relevance
between patient health engagement and medication-taking
behavior require further investigation considering a revised
MMAS-8 or other questionnaires and some objective indexes
such as pharmacy refill records and pill counts (Santra,
2015).
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